Oncology Billing Services in Washington
Washington's oncology practices face unique billing challenges shaped by Premera Blue Cross / Regence's commercial rules, Apple Health requirements, and Noridian Medicare policies. Our AAPC-certified coders specialize in both WA payer rules and oncology coding complexity.
Why Washington Oncology Practices Need Specialized Billing
Washington's healthcare market includes 22,000+ physicians, and oncology practices here face a payer market dominated by Premera Blue Cross / Regence on the commercial side and Apple Health on the public payer side. Medicare claims are processed through Noridian, which applies its own Local Coverage Determinations that directly affect oncology procedure coverage and medical necessity requirements. Generic billing teams without WA specific knowledge leave revenue on the table.
Oncology billing itself is complex. Oncology billing involves chemotherapy/infusion administration codes (96413-96417), drug product codes (J-codes), radiation therapy coding (77385-77387), and high-complexity E/M for treatment planning. Drug reimbursement (buy and bill) is a significant revenue component. When you combine this coding complexity with Washington's specific payer rules, authorization requirements, and 5 Apple Health managed care plans that each have their own billing rules, you need a team that understands both dimensions. Go Medical Billing provides that expertise at 2.49% of collections, serving oncology practices from Seattle to Vancouver and across Washington.
Top CPT Codes for Oncology in Washington
Our WA coders handle these oncology codes daily, applying Noridian Medicare rules and Premera Blue Cross / Regence commercial policies to each claim.
Washington Payer Challenges for Oncology
Every WA payer has specific rules for oncology claims. Here's how we navigate them.
Premera Blue Cross / Regence Oncology Claims
Premera Blue Cross / Regence processes the largest share of Washington commercial oncology claims. We know their WA specific fee schedules, prior authorization requirements for oncology procedures, and their appeal timelines when claims are denied. Correct HCPCS drug codes with exact dosage units. NDC numbers required by many payers.
Apple Health Oncology Billing
Apple Health routes oncology patients through 5 managed care plans: Molina, Coordinated Care, Community Health Plan, and 2 more. Each MCO has its own oncology authorization and billing rules that we manage.
Medicare (Noridian) Oncology Coverage
Noridian processes Medicare oncology claims in Washington with its own Local Coverage Determinations. We navigate Noridian's policies around infusion administration to prevent medical necessity denials.
Denial Prevention for Washington Oncology
Common oncology denials in Washington include correct hcpcs drug codes with exact dosage units and sequential, concurrent, and add-on infusion codes based on timing and technique. Our team catches these issues before submission and appeals aggressively with WA payer-specific documentation when denials occur.
Get Expert Oncology Billing in Washington
Free billing assessment for your WA oncology practice. See where revenue is leaking.
What We Handle for Washington Oncology Practices
Washington Oncology Billing Cost Comparison
Hiring an in-house biller with oncology expertise in Washington costs $45K-$60K annually in salary alone. Add benefits, software, clearinghouse fees, and office space, and the true cost is even higher. At 2.49% of collections, Go Medical Billing provides an entire team of AAPC-certified oncology coders and WA payer specialists for a fraction of that cost.
$45K-$60K
In-House Biller Salary
+ benefits, software, space
2.49%
Go Medical Billing Rate
Full team, all services included
60-80%
Typical Cost Reduction
With better results
Related Pages
Explore our Washington and oncology billing resources.
Frequently Asked Questions
Fix Your Washington Oncology Billing
Call 888-701-6090 for a free billing assessment specific to your WA oncology practice. We'll show you where revenue is leaking and how to fix it.